Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Total Liabilities (2020 - 2025)

Definitive Healthcare's Total Liabilities history spans 6 years, with the latest figure at $356.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 26.07% year-over-year to $356.5 million; the TTM value through Dec 2025 reached $356.5 million, down 26.07%, while the annual FY2025 figure was $356.5 million, 26.07% down from the prior year.
  • Total Liabilities reached $356.5 million in Q4 2025 per DH's latest filing, down from $365.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $653.0 million in Q1 2023 to a low of $356.5 million in Q4 2025.
  • Average Total Liabilities over 5 years is $551.2 million, with a median of $603.3 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: increased 16.6% in 2022, then tumbled 39.4% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $617.8 million in 2021, then rose by 3.71% to $640.7 million in 2022, then decreased by 2.18% to $626.7 million in 2023, then fell by 23.06% to $482.2 million in 2024, then decreased by 26.07% to $356.5 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Total Liabilities are $356.5 million (Q4 2025), $365.9 million (Q3 2025), and $358.9 million (Q2 2025).